Arcadia Biosciences, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Arcadia Biosciences, Inc. (RKDA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $3.88 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-03-26
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $11.17, a 1127.47% increase year-over-year.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $0.91, a 69.97% decline year-over-year.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-03-31 was $3.03, a 38.29% decline year-over-year.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $3.88, a 29.33% increase from fiscal 2024.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $3.00, a 50.00% decline from fiscal 2023.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $6.00, a 86.36% decline from fiscal 2022.
- Arcadia Biosciences, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $44.00, a 60.14% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $3.88 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $3.88 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | $3.88 10-Q · filed 2025-08-14 | ||||
| 2024-12-31 | $3.00 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $2.71 10-Q · filed 2024-11-12 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 | ||||
| 2023-12-31 | $6.00 10-K · filed 2025-03-25 | $6.38 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $6.38 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $6.38 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | $11.17 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $44.00 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $1.11 10-Q · filed 2022-11-10 | ||||
| 2022-06-30 | $1.16 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | $0.91 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | $110.40 10-K · filed 2023-03-30 | $2.76 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $2.85 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $2.88 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | $3.03 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $4.28 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $4.32 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | $4.45 10-Q · filed 2020-08-13 | ||||
| 2020-03-31 | $4.91 10-Q · filed 2020-05-13 | ||||
| 2019-12-31 | $5.13 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $5.16 10-Q · filed 2019-11-06 | ||||
| 2019-06-30 | $5.15 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $3.57 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | $6.65 10-K · filed 2020-03-25 | ||||
| 2018-09-30 | $6.76 10-Q · filed 2018-11-07 | ||||
| 2018-06-30 | $18.27 10-Q · filed 2018-08-08 | ||||
| 2018-03-31 | $45.69 10-Q · filed 2018-05-09 | ||||
| 2017-12-31 | $9.20 10-K · filed 2019-04-01 | $13.47 10-K · filed 2018-03-20 | |||
| 2017-09-30 | $0.68 10-Q · filed 2017-11-09 | ||||
| 2017-06-30 | $0.71 10-Q · filed 2017-08-10 | ||||
| 2016-12-31 | $103.50 10-K · filed 2018-03-20 | $5.17 10-K · filed 2017-03-08 | |||
| 2016-09-30 | $5.27 10-Q · filed 2016-11-10 | ||||
| 2016-06-30 | $6.36 10-Q · filed 2016-08-09 | ||||
| 2015-12-31 | $7.30 10-K · filed 2017-03-08 | ||||
| 2014-12-31 | $6.12 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| New Concept Energy, Inc. (GBR) | United States | $0.004B | |
| Trio Petroleum Corp (TPET) | United States | $0.009B | |
| AleAnna, Inc. (ANNA) | United States | $0.013B | |
| BARNWELL INDUSTRIES INC (BRN) | United States | $0.014B | -2.71 |
| CKX LANDS, INC. (CKX) | United States | $0.022B | 7.62 |
| MEXCO ENERGY CORP (MXC) | United States | $0.022B | 10.07 |
| EON Resources Inc. (EONR) | United States | $0.026B | |
| Prairie Operating Co. (PROP) | United States | $0.047B | -1.72 |
| ABUNDIA GLOBAL IMPACT GROUP, INC. (AGIG) | United States | $0.057B | -1.20 |
| BATTALION OIL CORP (BATL) | United States | $0.064B |